http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 421 reviews. 421 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Unison

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Unison uses and description

Sort by popularity
Unison - Pharmacology: Interferes with or inhibits microbial protein synthesis.

Indication: Treatment of infections caused by susceptible strains of specific microorganisms; serious systemic infections for which less potentially dangerous drugs are ineffective or contraindicated.

Unison is a broad-spectrum antibiotic that was derived from the bacterium Streptomyces venezuelae and is now produced synthetically. Unison is effective against a wide variety of microorganisms, but due to serious side-effects (e.g., damage to the bone marrow, including aplastic anemia) in humans, it is usually reserved for the treatment of serious and life-threatening infections (e.g., typhoid fever). Unison is bacteriostatic but may be bactericidal in high concentrations or when used against highly susceptible organisms. Unison stops bacterial growth by binding to the bacterial ribosome (blocking peptidyl transferase) and inhibiting protein synthesis.

Oral Bacterial meningitis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Brain abscess

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Granuloma inguinale

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Anthrax

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Listeriosis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Gas gangrene

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Whipple's disease

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Severe systemic infections with Camphylobacter fetus

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Infections caused by H. influenzae

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Ehrlichiosis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Severe gastroenteritis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Severe melioidosis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Plague

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Psittacosis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Q fever

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Anaerobic bacterial infections

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Tularaemia

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Ophthalmic Ocular infections

Adult: Instill 1 drop of a 0.5% solution every 2 hr. Increase dosage interval upon improvement. To continue treatment for at least 48 hr after complete healing. Reduce dose once symptoms are controlled or apply a 1% ointment 3-4 times daily. Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Otic/Aural Otitis externa

Adult: Instill 2-3 drops of a 5% solution into the ear bid-tid. Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required.

Unison is a bacteriostatic antimicrobial. It is considered a prototypical broad-spectrum antibiotic, alongside the tetracyclines.

Unison is effective against a wide variety of Gram-positive and Gram-negative bacteria, including most anaerobic organisms. Due to resistance and safety concerns, it is no longer a first-line agent for any indication in developed nations, although it is sometimes used topically for eye infections; nevertheless, the global problem of advancing bacterial resistance to newer drugs has led to renewed interest in its use. In low-income countries, Unison is still widely used because it is exceedingly inexpensive and readily available.

The most serious adverse effect associated with Unison treatment is bone marrow toxicity, which may occur in two distinct forms: bone marrow suppression, which is a direct toxic effect of the drug and is usually reversible, and aplastic anemia, which is idiosyncratic (rare, unpredictable, and unrelated to dose) and generally fatal.

Oral Bacterial meningitis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Anaerobic infections

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Brain abscess

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Granuloma inguinale

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Plague and tularaemia

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Anthrax

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Listeriosis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Gas gangrenes

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Whipple's disease

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Severe systemic infections with Camphylobacter fetus

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Infections due to H. influenzae

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Ehrlichiosis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Severe gastroenteritis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Severe melioidosis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Psittacosis

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Oral Q fever

Adult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient's temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.

Child: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.

Elderly: Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Ophthalmic Eye infections

Adult: Instill 1 drop of a 0.5% solution every 2 hr. Increase dosage interval upon improvement. To continue treatment for at least 48 hr after complete healing. Reduce dose once symptoms are controlled or apply a 1% ointment 3-4 times daily. Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required. Otic/Aural otitis externa

Adult: Instill 2-3 drops of a 5% solution into the ear bid-tid. Renal impairment: Dose reduction may be required. Hepatic impairment: Dose reduction may be required.

Indications:

Adult: PO Susceptible infections 50 mg/kg/day in 4 divided doses, may increase to 100 mg/kg/day in more severe infections. Ophth Ocular infections As 0.5% soln: Instill 1 drop 2 hrly, then adjust dosage interval upon improvement. Otic Otitis externa As 5% soln: Instill 2-3 drops 2-3 times/day.

Unison is indicated for the topical treatment of infections due to micro-organisms sensitive to the anti-infective.

Indications: Enteric fever (Typhoid and Para typhoid).

H.

Influenzae meningitis.

Anaerobic infections, intraocular infections, urinary tract infections, conjunctivitis, external ear infections.

Corneal ulcer, bacterial conjunctivitis, trachoma, ocular infections.

Otitis externa, chronic otitis media.

Pre and post antral or mastoid surgery.

Active ingredients: Chloramphenicol
Unit description, dosagePrice, USD

List of unison brand and generic drugs

Unimycetin
Unison Ointment (Myanmar)
Ointment; Topical; Chloramphenicol
Unison Ointment 1 % x 15 g x 24 's
Ursa-Fenol (Greece)
Ursafenol (Greece)
Vanafen
Vanafen Ophtalmic (Thailand)
Vanafen Ophthalmic (Thailand)
Vanafen Ophthalmic 1 % x 5 g
Vanafen Otologic (Thailand)
Vanafen Otologic 1 % x 10 mL
Vanafen S (Thailand)
Vanafen S 0.5 % x 5 mL
Vanafen S 0.5 % x 10 mL
Vanafen-S
Vanmycetin (India, Oman)
Vanmycetin 1% CAP / 50$ 0.62
1 % x 50's$ 0.62
Vanmycetin Eye 5 ml Drop$ 0.20
VANMYCETIN EYE
VANMYCETIN EYE Eye - Ear Drops / 0.4(%) (5ml units)$ 0.20
VANMYCETIN EYE Applicaps / 1(%) (50 units)$ 0.42
Vanmycetin Opticops
Vanmycetin Opticops Eye Aplicaps$ 0.01
Vecol (India)
Vecol 0.4% w/v EYE-DPS / 5ml$ 0.29
0.4 % w/v x 5ml$ 0.29
Vecol Eye 5 ml Drop$ 0.29
Venimicetin (Philippines)
Venimicetin 250 mg x 100's$ 15.07
Venimicetin 500 mg x 100's
Venimicetin 125 mg/5 mL x 60 mL$ 2.12
Veticol
Vetrocloricin (United States)
Viceton (United States)
Vinkol
Vinkol 250 mg Capsule$ 0.01
Visalmin
Vista-Phenicol
Vistachlor (Philippines)
Vistachlor 5 mg/1 mL x 5 mL
Vitamfenicolo (Italy)
Vitamycetin (India)
Vitamycetin 250mg CAP / 8$ 0.10
Vitamycetin 125mg/5mL SYR / 40ml$ 0.15
Vitamycetin 125mg/5mL SYR / 80ml$ 0.23
250 mg x 8's$ 0.10
125 mg x 5 mL x 40ml$ 0.15
125 mg x 5 mL x 80ml$ 0.23
Vitamycetin 80 ml Suspension$ 0.01
Vitamycetin 250 mg Capsule$ 0.01
Vitamycetin 40 ml Suspension$ 0.02
Vitchol
Vitchol 500 mg Capsule$ 0.07

Show all Unison generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer